These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 16197471
1. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma. Hoshino M, Fujita Y, Saji J, Inoue T, Nakagawa T, Miyazawa T. Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471 [Abstract] [Full Text] [Related]
6. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate. Kimata H. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221 [Abstract] [Full Text] [Related]
7. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, Ito T, Ito N, Sasaki M, Miura M. Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601 [Abstract] [Full Text] [Related]
8. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study. Yoshihara S, Fukuda H, Arisaka O. Arzneimittelforschung; 2011 Jun; 61(7):421-4. PubMed ID: 21899211 [Abstract] [Full Text] [Related]
9. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report. Umemoto S, Itagaki K, Kimura M, Itoh S, Tanaka M, Haraguchi M, Matsuzaki M. Heart Vessels; 2003 May; 18(2):100-2. PubMed ID: 12756607 [Abstract] [Full Text] [Related]
12. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate]. Yamasawa H, Oshikawa K, Sugiyama Y. Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513 [Abstract] [Full Text] [Related]
13. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies. Furukido K, Takeno S, Ueda T, Hirakawa K, Yajin K. Am J Rhinol; 2002 Jun; 16(6):329-36. PubMed ID: 12512908 [Abstract] [Full Text] [Related]
14. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis. Washio Y, Ohashi Y, Tanaka A, Kakinoki Y, Sugiura Y, Sakamoto H, Yamada K, Matsuda M, Uekawa M, Okamoto H, Nakai Y. Acta Otolaryngol Suppl; 1998 Jun; 538():126-32. PubMed ID: 9879412 [Abstract] [Full Text] [Related]
15. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats. Shimizu S, Hattori R, Majima Y, Shimizu T. Ann Otol Rhinol Laryngol; 2009 Jan; 118(1):67-72. PubMed ID: 19244966 [Abstract] [Full Text] [Related]
16. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters]. Higashi N, Niimi Y, Aoki M, Fujimoto K, Suzuki K, Numano K, Kawana S. Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038 [Abstract] [Full Text] [Related]
17. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5. Murakami T, Yamanaka K, Tokime K, Kurokawa I, Tsutsui H, Nakanishi K, Mizutani H. Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748 [Abstract] [Full Text] [Related]
18. Progress in suplatast tosilate research. Sano Y, Yamada H. Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190 [No Abstract] [Full Text] [Related]